FocusAlzheimer’s Disease

The A4 Study: Stopping AD Before Symptoms Begin?

See allHide authors and affiliations

Science Translational Medicine  19 Mar 2014:
Vol. 6, Issue 228, pp. 228fs13
DOI: 10.1126/scitranslmed.3007941

You are currently viewing the abstract.

View Full Text


A new secondary prevention trial in older people with amyloid accumulation at high risk for Alzheimer’s disease dementia should provide insights into whether anti-amyloid therapy can delay cognitive decline.

View Full Text